Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ABBOTT LABORATORIES
10/18/17 | 01:30pm Q3 2017 Earnings Release
10/18/17 | 03:00pm Q3 2017 Earnings Call
01/24/18 FY 2017 Earnings Release (Projected)
Past events on ABBOTT LABORATORIES
10/12/17 ex-dividend day
07/20/17 | 03:00pm Interim 2017 Earnings Call
07/20/17 | 01:45pm Interim 2017 Earnings Release
07/12/17 ex-dividend day
Upcoming sector events for ABBOTT LABORATORIES
10/17/17 MERCK & CO., INC. : Lung Cancer World Conference - Abstract P2.01-040
10/17/17 | 02:30am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract #P2.07-011
10/17/17 | 02:30am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract #P2.07-034
10/17/17 | 08:45am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract #MA 18.14
Past sector events for ABBOTT LABORATORIES
10/16/17 | 02:30am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract #P1.04-010
10/16/17 | 02:30am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract #P1.03-026
10/16/17 | 02:30am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract # P1.01-051
10/16/17 | 09:30am TAKEDA PHARMACEUTICAL CO LTD : International Association for the Study of Lung Cancer Conference - Abstract 8027
Annual publications
Previous yearNext Year
Annual results2014201520162017 (e)2018 (e)
Sales
Million $
Released
Forecast
Spread
20 247
20 371
-0,61%
20 405
20 437
-0,16%
20 853
20 898
-0,22%

26 611

28 374
Operating income (EBITDA)
Million $
Released
Forecast
Spread
3 865
5 230
-26%
4 850
5 068
-4,3%
4 975
5 048
-1,4%

7 100

7 774
Operating profit (EBIT)
Million $
Released
Forecast
Spread
2 872
3 787
-24%
3 979
3 921
1,5%
4 172
4 077
2,3%

5 956

6 571
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
2 284
2 513
-9,1%
4 423
3 351
32%
1 400
1 666
-16%

2 183

3 371
EPS
 $
Released
Forecast
Spread
1,49
1,25
19%
2,92
2,35
24%
0,94
1,79
-47%

1,05

1,72
Announcement Date01/29/201501/28/201601/25/2017

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ4
2016
Q1
2017
Q2
2017
Q3
2017 (e)
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
5 333
5 381
-0,88%
6 335
6 151
3,0%
6 637
6 635
0,04%

6 717

6 921
Operating income (EBITDA)
Million $
Released
Forecast
Spread
1 415
1 439
-1,7%
1 441
1 390
3,7%
1 731
1 730
0,04%

1 826

2 012
Operating profit (EBIT)
Million $
Released
Forecast
Spread
1 217
1 191
2,2%
1 189
1 088
9,3%
1 475
1 455
1,4%

1 549

1 738
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
798
821
-2,8%
419
670
-37%
283
617
-54%

525

778
EPS
 $
Released
Forecast
Spread
0,53
0,58
-8,1%
0,24
0,42
-43%
0,16
0,37
-57%

0,31

0,40
Announcement Date01/25/201704/19/201707/20/2017

© 2017 Thomson Reuters
© 2017 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise